1
Clinical Trials associated with Dengue (Asterivir)Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TDV) Administered Subcutaneously in Healthy Children Aged 4 – 16 Years Old
Start Date19 Aug 2016 |
Sponsor / Collaborator- |
100 Clinical Results associated with Dengue (Asterivir)
100 Translational Medicine associated with Dengue (Asterivir)
100 Patents (Medical) associated with Dengue (Asterivir)
100 Deals associated with Dengue (Asterivir)